Copyright
©The Author(s) 2020.
World J Diabetes. Oct 15, 2020; 11(10): 435-446
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.435
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.435
Index | DM (n = 373) | Non-DM (n = 692) | P |
Clinical manifestation | |||
Fever | 115 (30.8) | 253 (36.6) | 0.061 |
Abdominal pain | 300 (80.4) | 552 (79.8) | 0.797 |
PD cell count on admission(/μL) | 1920 (620, 5350) | 1847 (613, 4974) | 0.791 |
Laboratory test | |||
WBC (1012/L) | 8.27 (6.57, 10.98) | 8.29 (6.09, 11.43) | 0.903 |
Hb (g/L) | 97 (84, 109) | 99 (85, 113) | 0.128 |
Alb (g/dL) | 28.24 ± 6.24 | 29.42 ± 6.29 | 0.003 |
BUN (mmol/L) | 14.85 (10.79, 20.16) | 15.68 (12.01, 19.92) | 0.090 |
Scr (μmol/L) | 672.66 (511.00, 854.50) | 735.60 (511.00, 954.35) | 0 |
eGFR | 6.29 (4.68, 8.38) | 5.70 (4.35, 7.28) | 0 |
Organism (n, %) | DM (n = 373) | Non-DM (n = 692) | P |
Gram-positive | 172 (46.1) | 259 (37.4) | 0.006 |
Coagulase-negative staphylococcus | 103 (27.6) | 130 (18.8) | 0.001 |
Staphylococcus aureus | 22 (5.9) | 26 (3.8) | 0.108 |
Streptococcus species | 30 (8.0) | 59 (8.5) | 0.786 |
Enterococcus species | 8 (2.1) | 11 (1.6) | 0.514 |
Other gram-positive | 9 (2.4) | 33 (4.8) | 0.060 |
Gram-negative | 74 (19.8) | 170 (24.6) | 0.080 |
Escherichia coli | 26 (6.7) | 73 (10.5) | 0.038 |
Klebsiella species | 6 (1.6) | 20 (2.9) | 0.196 |
Acinetobacter baumannii | 7 (1.9) | 17 (2.5) | 0.543 |
Pseudomonas aeruginosa | 5 (1.3) | 27 (3.9) | 0.020 |
Other gram-negative | 31 (8.3) | 32 (4.6) | 0.015 |
Fungi | 13 (3.5) | 30 (4.3) | 0.501 |
Mycobacterium tuberculosis | 2 (0.5) | 8 (1.2) | 0.508 |
Polymicrobial | 24 (6.4) | 55 (7.9) | 0.369 |
Culture-negative | 84 (22.5) | 163 (23.6) | 0.703 |
No culture | 4 (1.1) | 7 (1.0) | 1.000 |
Variable | DM (n = 214) | Non-DM (n = 395) | P |
Demographic characteristics | |||
Age (yr) | 61 (54, 68) | 55 (42, 68) | 0 |
Gender (male, n, %) | 117 (54.7) | 185 (48.6) | 0.065 |
No. of PDAP episodes, n (%) | 0.596 | ||
1 | 127 (59.3) | 230 (58.2) | |
2 | 51 (23.8) | 86 (21.8) | |
≥ 3 | 36 (16.8) | 79 (20.0) | |
CVD | 77 (36.0) | 104 (26.3) | 0.013 |
Laboratory test | |||
WBC (1012/L) | 8.41 (6.90,10.62) | 8.26 (5.99,11.29) | 0.411 |
Hb (g/L) | 96 (80, 108) | 98 (83, 111) | 0.089 |
Alb (g/dL) | 28.34 ± 6.74 | 29.60 ± 5.88 | 0.017 |
BUN (mmol/L) | 14.9 (10.2, 20.5) | 16.0 (12.5, 20.2) | 0.062 |
Scr (μmol/L) | 654.7 (480.0, 858.0) | 745.3 (575.2, 972.2) | 0.001 |
eGFR | 6.46 (4.61, 8.55) | 5.51 (4.23, 7.17) | 0 |
PD cell count on admission(/μL) | 1799.5 (571.0, 5040.0) | 2040 (739.0, 5219.5) | 0.330 |
- Citation: Meng LF, Yang LM, Zhu XY, Zhang XX, Li XY, Zhao J, Liu SC, Zhuang XH, Luo P, Cui WP. Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: A multicenter retrospective cohort study. World J Diabetes 2020; 11(10): 435-446
- URL: https://www.wjgnet.com/1948-9358/full/v11/i10/435.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i10.435